Delivery Order SPE2DB20D1100-SPE2DB24FD1G7

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a ceiling value of $2,361.84 and a completion date of December 27, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML medication. The contract is a firm fixed price agreement with a ceiling value of $1,022.56 and a completion date of September 5, 2024. There is no set-aside designation for this award. AmerisourceBergen, through its Corporate Office division, will be responsible for delivering the requested medication to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, and has a ceiling value of $1,064.68. The contract is a firm fixed-price delivery order, with a period of performance through February 19, 2025. This contract award is not associated with a set-aside program. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) with a ceiling value of $1,671.20 and an ultimate completion date of August 9, 2024. The award does not have a set-aside designation. Amerisourcebergen, through its corporate office division, will provide the medication to...
This is a $1,671.20 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication, to support federal healthcare requirements. The delivery order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 2, 2024. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $1,002.72 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a medication. There is no set-aside designation for this contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the pharmaceutical product "EMGALITY 120 MG/ML PENML" and has a ceiling value of $1,800. The contract is a Firm Fixed Price agreement with an ultimate completion date of January 29, 2025. This Delivery Order is under a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed price of $1,069.80 and a period of performance through July 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty medications, generic drugs, vaccines, and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a medical product, with a ceiling value of $2,906.88 and a completion date of January 6, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD1G7
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The delivery order has a ceiling value of $1,853.68 and is on a Firm Fixed Price basis. This contract is not associated with a set-aside program and has an ultimate completion date of August 7, 2024. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been awarded numerous federal contracts and indefinite delivery contracts to provide a wide range of pharmaceutical and medical products to various defense and civilian agencies, including the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation. These contracts enable the government to efficiently procure essential medical supplies and medications to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/5/24, 9:19 AM